Malignant Paranasal Sinus Neoplasm — knowledge graph · CancerIndex

Knowledge graph · Cancer

Malignant Paranasal Sinus Neoplasm

subtype

Identifier: CI-CAN-00003208
Entity page: /cancer/malignant-paranasal-sinus-neoplasm ↗
Edges: 36

Neighbours: 13 drugs10 trials
Drawn: 23 of 23 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Malignant Paranasal Sinus Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived13 of 13
→ investigated in trials for	Cisplatinsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Paranasal Sinus Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Pembrolizumabmonoclonal antibody 3 trials (3 active) · roll-up of the cancer and its descendants

Malignant Paranasal Sinus Neoplasm studied in …STUDIED_INderived10 of 23show all (up to 200)
→ studied in	NCT05172245Phase 1 · recruiting Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer · condition mapped CURATED_BROADER · 23 trials mapped (10 active)	—	—	Paranasal Sinus Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07156227Phase 1 · recruiting Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 23 trials mapped (10 active)	—	—	Paranasal Sinus Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04576091Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer · condition mapped CURATED_BROADER · 23 trials mapped (10 active)	—	—	Paranasal Sinus Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05075980Phase 2 · active not recruiting Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study · condition mapped ONTOLOGY_EXACT · 23 trials mapped (10 active)	—	—	Paranasal Sinus Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06662058NA · recruiting Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation · condition mapped CURATED_BROADER · 23 trials mapped (10 active)	—	—	Paranasal Sinus Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02012699recruiting Integrated Cancer Repository for Cancer Research · condition mapped ALIAS · 23 trials mapped (10 active)	—	—	Malignant Paranasal Sinus Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 23 trials mapped (10 active)	—	—	Paranasal Sinus Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04870762Phase 2 · recruiting Customized 3D Printed Oral Stents During Head and Neck Radiotherapy · condition mapped ONTOLOGY_EXACT · 23 trials mapped (10 active)	—	—	Maxillary Sinus Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03370276Phase 1/Phase 2 · completed Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma · condition mapped ALIAS · 23 trials mapped (10 active)	—	—	Paranasal Sinus Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06636734Phase 2 · recruiting Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial · condition mapped CURATED_BROADER · 23 trials mapped (10 active)	—	—	Paranasal Sinus Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →